eFFECTOR Therapeutics (EFTR) Enterprise Value
Price: $0.00
Market Cap: $941
Avg Volume: 851
Market Cap: $941
Avg Volume: 851
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to eFFECTOR Therapeutics's latest quarterly financial reports:
- The enterprise value (EV) is 68.70M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 25.57M, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $15.67, with 4.08M shares outstanding.
- The company has 15.51M in cash and cash equivalents and 20.25M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$68.70M
Market Cap
$63.96M
Total Debt
$20.25M
Cash and Equivalents
$15.51M
Historical Enterprise Value
eFFECTOR Therapeutics Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-03-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| March 31, 2024 | $68.70M | 91.99% | $15.67 | 4.08M | $63.96M | $15.51M | $20.25M |
| December 31, 2023 | $35.78M | -31.39% | $11.69 | 2.67M | $31.21M | $14.88M | $19.45M |
| September 30, 2023 | $52.15M | 14.84% | $15 | 2.47M | $37.06M | $5.39M | $20.48M |
| June 30, 2023 | $45.41M | 82.72% | $20.76 | 1.91M | $39.72M | $14.71M | $20.41M |
| March 31, 2023 | $24.85M | -15.32% | $8.82 | 1.68M | $14.82M | $10.31M | $20.35M |
| December 31, 2022 | $29.35M | -7.89% | $10.69 | 1.66M | $17.78M | $8.71M | $20.28M |
| September 30, 2022 | $31.86M | -48.76% | $14.3 | 1.65M | $23.55M | $11.90M | $20.22M |
| June 30, 2022 | $62.19M | -64.74% | $35.5 | 1.64M | $58.39M | $16.35M | $20.15M |
| March 31, 2022 | $176.37M | -42.13% | $100.25 | 1.74M | $173.96M | $17.66M | $20.07M |
| December 31, 2021 | $304.76M | -42.74% | $207 | 1.62M | $334.43M | $49.70M | $20.03M |
| September 30, 2021 | $532.21M | 129.48% | $351.25 | 1.61M | $567.19M | $54.77M | $19.79M |
| June 30, 2021 | $231.92M | 57.06% | $247.25 | 902.25K | $223.08M | $10.88M | $19.72M |
| March 31, 2021 | $147.67M | 0.70% | $243.72 | 598.56K | $145.88M | $16.77M | $18.56M |
| December 31, 2020 | $146.64M | -1.51% | $248.75 | 598.56K | $148.89M | $15.22M | $12.96M |
| September 30, 2020 | $148.89M | 985.01% | $248.75 | 598.56K | $148.89M | $- | $- |
| June 30, 2020 | $13.72M | -19.98% | $248.75 | 55.17K | $13.72M | $- | $- |
| March 31, 2020 | $17.15M | - | $248.75 | 55.17K | $13.72M | $-3.43M | $- |
Related Metrics
Explore detailed financial metrics and analysis for EFTR.